Gabriel Liberatore

Non-Executive Director / OncoSil Medical

Dr Liberatore is a biopharmaceutical executive with over 25 years experience in senior Business Development, R&D and strategic operational management positions including taking products to market. Until recently, he was the Group Chief Operating Officer at Telix Pharmaceuticals (ASX:TLX) a global biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic radiopharmaceuticals. Currently, Dr Liberatore is a Strategic Advisor to GlyTherix Ltd, an Australian immuno-oncology company specializing in developing antibody radiopharmaceuticals for solid tumours.

Lists and Charts

Roles

2023

Non-Executive Director

OncoSil Medical

Year started and most recent title

Total Shareholder Return as at 02/12/24

Rank	Company	1 Yr	5 Yr
927^th	Comet Ridge">Comet Ridge	-5.71%	-3.29%
928^th	Nova Minerals">Nova Minerals	-5.77%	-5.78%
929^th	OncoSil Medical">OncoSil Medical	-5.87%	-43.38%
930^th	Kaiser Reef">Kaiser Reef	-5.88%	0%
931^st	Jcurve Solutions">Jcurve Solutions	-5.88%	4.42%

View Full List

1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Person Activity

NEW ROLE: Non-Executive Director, OncoSil Medical

07 Aug 2024

Related Information

Access to our data for Gabriel Liberatore is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Gabriel Liberatore is linked to 1 organisation which is included in 1 list - Public Companies - non WA.

To see the data you will need to Subscribe.